Dravet syndrome as epileptic encephalopathy: Evidence from long-term course and neuropathology

Brain

Volumn 134, Issue 10, 2011, Pages 2982-3010

  Catarino, Claudia B ^a,b   Liu, Joan Y W ^a   Liagkouras, Ioannis ^a   Gibbons, Vaneesha S ^a   Labrum, Robyn W ^a   Ellis, Rachael ^c   Woodward, Cathy ^a   Davis, Mary B ^a   Smith, Shelagh J ^a,b   Cross, J Helen ^d,e,f   Appleton, Richard E ^g   Yendle, Simone C ^h   McMahon, Jacinta M ^h   Bellows, Susannah T ^h   Jacques, Thomas S ^d,e   Zuberi, Sameer M ^c   Koepp, Matthias J ^a,b   Martinian, Lillian ^a   Scheffer, Ingrid E ^h   Thom, Maria ^a   Sisodiya, Sanjay M ^a,b   more..

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f YOUNG EPILEPSY   (United Kingdom)

^g ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

encephalopathy; epilepsy; neuropathology; SCN1A

Indexed keywords

ACETAZOLAMIDE; CALBINDIN; CALRETININ; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; NEUROPEPTIDE Y; NITRAZEPAM; OXCARBAZEPINE; PARVALBUMIN; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PREGABALIN; PRIMIDONE; RUFINAMIDE; SODIUM CHANNEL NAV1.1; STIRIPENTOL; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN DISEASE; BRAIN STEM; BRAIN TISSUE; CEREBELLUM; CEREBELLUM ATROPHY; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSPHAGIA; ELECTROENCEPHALOGRAPHY; FEBRILE CONVULSION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MENTAL DEFICIENCY; MENTAL DETERIORATION; MISSENSE MUTATION; MORBIDITY; MOTOR DYSFUNCTION; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SOCIAL STATUS; TEMPORAL LOBECTOMY; VAGUS NERVE STIMULATION;

EID: 80054087471     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr129     Document Type: Article

References (84)

1. Akiyama M, Kobayashi K, Yoshinaga H, Ohtsuka Y. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 2010; 51: 1043-52.
2. Auvin S, Dulac O, Vallée L. Do SCN1A mutations protect from hippo-campal sclerosis? Epilepsia 2008; 49: 1107-8. (Pubitemid 351794004)
3. Baulac S, Gourfinkel-An I, Nabbout R, Huberfeld G, Serratosa J, Leguern E, et al. Fever, genes, and epilepsy. Lancet Neurol 2004; 3: 421-30. (Pubitemid 38796480)
4. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-85.
5. Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, Wirrell EC, et al. De novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006; 5: 488-92.
6. Black JA, Yokoyama S, Waxman SG, Oh Y, Zur KB, Sontheimer H, et al. Sodium channel mRNAs in cultured spinal cord astrocytes: in situ hybridization in identified cell types. Brain Res Mol Brain Res 1994; 23: 235-45. (Pubitemid 24122652)
7. Blü mcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158-74.
8. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A. A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol 2010; 20: 451-8.
9. Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci 2008; 28: 11768-77.
10. Chipaux M, Villeneuve N, Sabouraud P, Desguerre I, Boddaert N, Depienne C, et al. Unusual consequences of status epilepticus in Dravet syndrome. Seizure 2010; 19: 190-4.
11. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001; 68: 1327-32. (Pubitemid 32510608)
12. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
13. Crooks R, Mitchell T, Thom M. Patterns of cerebellar atrophy in patients with chronic epilepsy: a quantitative neuropathological study. Epilepsy Res 2000; 41: 63-73. (Pubitemid 30621402)
14. Davidsson J, Collin A, Olsson ME, Lundgren J, Soller M. Deletion of the SCN gene cluster on 2q24.4 is associated with severe epilepsy: an array-based genotype-phenotype correlation and a comprehensive review of previously published cases. Epilepsy Res 2008; 81: 69-79.
15. Deng YH, Berkovic SF, Scheffer IE. GEFS+ where focal seizures evolve from generalized spike wave: video-EEG study of two children. Epileptic Disord 2007; 9: 307-14. (Pubitemid 47606314)
16. Depienne C, Arzimanoglou A, Trouillard O, Fedirko E, Baulac S, Saint-Martin C, et al. Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat 2006; 27: 389.
17. Depienne C, Bouteiller D, Keren B, Cheuret E, Poirier K, Trouillard O, et al. Sporadic Infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet Syndrome but mainly affects females. PLoS Genet 2009a; 5: e1000381.
18. Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 2009b; 46: 183-91.
19. Dibbens LM, Tarpey PS, Hynes K, Bayly MA, Scheffer IE, Smith R, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008; 40: 776-81. (Pubitemid 351748867)
20. Dravet C. Les epilepsies graves de l'enfant. Vie Med 1978; 8: 543-8.
21. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy (Dravet syndrome). In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolff P, editors. Epileptic syndromes in infancy, childhood and adolescence. 4th edn. France: John Libbey Eurotext; 2005. p. 89-113.
22. Duvernoy HM. The human hippocampus: an atlas of applied anatomy. München: Springer; 1988.
23. Eldridge R, Iivanainen M, Stern R, Koerber T, Wilder BJ. "Baltic" myo-clonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983; 2: 838-42. (Pubitemid 13009274)
24. Engel J Jr. International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803. (Pubitemid 32605946)
25. Fonseca CG, Green CR, Nicholson LF. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res 2002; 929: 105-16. (Pubitemid 34164415)
26. Fujiwara T. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res 2006; 70 (Suppl 1): S223-30.
27. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998; 39: 508-12. (Pubitemid 28221807)
28. Harkin LA, Bowser DN, Dibbens LM, Singh R, Phillips F, Wallace RH, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002; 70: 530-6. (Pubitemid 34112305)
29. Harkin LA, McMahon JM, Iona X, Dibbens L, Pelekanos JT, Zuberi SM, et al. The spectrum of SCN1A-related infantile epileptic encephalopa-thies. Brain 2007; 130: 843-52. (Pubitemid 46410748)
30. Haut SR, Veliskova J, Moshe SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 2004; 3: 608-17. (Pubitemid 39221927)
31. Hayashi M, Sugai K, Kurihara E, Tamagawa K. An autopsy case of severe myoclonic epilepsy of infancy, who died of acute encephalopathy associated with influenza infection. Epilepsia 2004; 45 (Suppl 8): 65 [Abstract].
32. Hurst DL. Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 1990; 31: 397-400. (Pubitemid 20226666)
33. Jansen FE, Sadleir LG, Harkin LA, Vadlamudi L, McMahon JM, Mulley JC, et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006; 67: 2224-6. (Pubitemid 46035482)
34. Kalume F, Yu FH, Westenbroek RE, Scheuer T, Catterall WA. Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci 2007; 27: 11065-74. (Pubitemid 47574172)
35. Kalviainen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E. Clinical Picture of EPM1-Unverricht-Lundborg disease. Epilepsia 2008; 49: 549-56. (Pubitemid 351661066)
36. Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 2004; 24: 2690-8. (Pubitemid 38380945)
37. Kanai K, Yoshida S, Hirose S, Oguni H, Kuwabara S, Sawai S, et al. Physicochemical property changes of amino acid residues that accompany missense mutations in SCN1A affect epilepsy phenotype severity. J Med Genet 2009; 46: 671-9.
38. Kearney JA, Wiste AK, Stephani U, Trudeau MM, Siegel A, RamanchandranNair R, et al. Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy. Pediatr Neurol 2006; 34: 116-20. (Pubitemid 43187982)
39. Kielian T. Glial connexins and gap junctions in CNS inflammation and disease. J Neurochem 2008; 106: 1000-16.
40. Le Gal F, Korff CM, Monso-Hinard C, Mund MT, et al. A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation. Epilepsia 2010; 51: 1915-8.
41. Livingston JH, Cross JH, Mclellan A, Birch R, Zuberi SM. A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus. J Child Neurol 2009; 24: 503-8.
42. Lossin C. A catalog of SCN1A variants. Brain Dev 2009; 31: 114-30.
43. Mancardi MM, Striano P, Gennaro E, Madia F, Paravidino R, Scapolan S, et al. Familial occurrence of febrile seizures and epilepsy in severe myoclonic epilepsy in infancy (SMEI) patients with SCN1A mutations. Epilepsia 2006; 47: 1629-35. (Pubitemid 44556396)
44. Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, et al. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 2009; 50: 1670-8.
45. Martin MS, Dutt K, Papale LA, Dube CM, Dutton SB, de Haan G, et al. Altered function of the SCN1A voltage-gated sodium channel leads to GABAergic interneuron abnormalities. J Biol Chem 2010; 285: 9823-34.
46. McArdle EJ, Kunic JD, George AL Jr. Novel SCN1A frameshift mutation with absence of truncated Nav1.1 protein in severe myoclonic epilepsy of infancy. Am J Med Genet A 2008; 146A: 2421-3.
47. McIntosh AM, McMahon J, Dibbens LM, Iona X, Scheffer IE, et al. Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol 2010; 9: 592-8.
48. Meisler MH, O'Brien JE, Sharkey LM. The sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol 2010; 588: 1841-8.
49. Mullen SA, Scheffer IE. Translational research in epilepsy genetics-sodium channels in man to interneuronopathy in mouse. Arch Neurol 2009; 66: 21-6.
50. Oakley JC, Kalume F, Yu FH, Scheuer T, Catterall WA. Temperature-and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. PNAS 2009; 106: 3994-9.
51. Ogawa K, Kanemoto K, Koyama M, Shirasaka Y, Kawasaki J, Yamasaki S. Dysphagia and long-term follow-up of Lennox-Gastaut. Seizure 2001; 10: 197-202.
52. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, et al. Nav1.1 Localizes to axons of parvalbumin-positive inhibitory inter-neurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007; 27: 5903-14. (Pubitemid 46849766)
53. Patino GA, Claes LRF, Lopez-Santiago LF, Slat EA, Dondeti RSR, Chen C, et al. A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci 2009; 29: 10764-78.
54. Pereira S, Vieira JP, Barroca F, Roll P, Carvalhas R, Cau P, et al. Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. Neurology 2004; 63: 191-2. (Pubitemid 38943811)
55. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39: 5-17. (Pubitemid 28116836)
56. Ragona F, Brazzo D, De Giorgi I, Morbi M, Freri E, Teutonico F, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Brain Dev 2010; 32: 71-7.
57. Ragona F, Granata T, Bernardina BD, Offredi F, Darra F, Battaglia D, et al. Cognitive development in Dravet syndrome: A retrospective, multicenter study of 26 patients. Epilepsia 2011; 52: 386-92.
58. Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008; 29: 142-60. (Pubitemid 350180489)
59. Renier WO, Renkawek K. Clinical and neuropathological findings in a case of severe myoclonic epilepsy of infancy. Epilepsia 1990; 31: 287-91. (Pubitemid 20181298)
60. Saemundsen E, Ludvingsson P, Rafnsson V. Risk of autism spectrum disorders after infantile spasms: a population-base study nested in a cohort with seizures in the first year of life. Epilepsia 2008; 49: 1865-70.
61. Sakakibara T, Nakagawa E, Saito Y, Sakuma H, Komaki H, Sugai K, et al. Hemiconvulsion-hemiplegia syndrome in a patient with severe myo-clonic epilepsy in infancy. Epilepsia 2009; 50: 2158-62.
62. Sakauchi M, Oguni H, Kato I, Osawa M, Hirose S, Kaneko S, et al. Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia 2011. Advance Access published on April 14th, 2011, doi:10.1111/j.1528-1167.2011.03053.x.
63. Sander JW, Barclay J, Shorvon SD. The neurological founding fathers of the National Society for Epilepsy and of the Chalfont Centre for Epilepsy. J Neurol Neurosurg Psychiatry 1993; 56: 599-604. (Pubitemid 23203756)
64. Scheffer IE. Does genotype determine phenotype? Sodium channel mutations in Dravet syndrome and GEFS+. Neurology 2011; 76: 588-9.
65. Scheffer IE, Zhang YH, Janssen FE, Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev 2009; 31: 394-400.
66. Shi X, Yasumoto S, Nakagawa E, Fukasawa T, Uchiya S, Hirose S. Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome. Brain Dev 2009; 31: 758-62.
67. Siegler Z, Barsi P, Neuwirth M, Jerney J, Kassay M, Janszky J, et al. Hippocampal sclerosis in severe myoclonic epilepsy in infancy: a retrospective MRI study. Epilepsia 2005; 46: 704-8. (Pubitemid 40628666)
68. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genetics 2009; 5: e1000649.
69. Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007b; 69: 250-4. (Pubitemid 47205686)
70. Striano P, Mancardi MM, Biancheri R, Madia F, Gennaro E, Paravidino R, et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia 2007a; 48: 1092-6. (Pubitemid 46854868)
71. Tang B, Dutt K, Papale L, Rusconi R, Shankar A, Hunter J, et al. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS + ) mutation. Neurobiol Dis 2009; 35: 91-102.
72. Tang S, Lin JP, Hughes E, Siddiqui A, Lim M, Lascelles K. Encephalopathy and SCN1A mutations. Epilepsia 2011; 52: e26-30.
73. Thom M, Martinian L, Catarino C, Yogarajah M, Koepp M, Caboclo L, et al. Bilateral synaptic reorganisation of the dentate gyrus in hippocampal sclerosis: a post-mortem study. Neurology 2009; 73: 1033-40.
74. Thom M, Liagkouras I, Elliot KJ, Martinian L, Harkness W, McEvoy A, et al. Reliability of patterns of hippocampal sclerosis as predictors of postsurgical outcome. Epilepsia 2010; 51: 1801-8.
75. Vezzani A, Balomo S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008; 22: 797-803.
76. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-43. (Pubitemid 44921957)
77. Vezzani A, Sperk G, Colmers WF. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 1999; 22: 25-30. (Pubitemid 29130080)
78. Wallace RH, Hodgson BL, Grinton BE, Gardiner RM, Robinson R, Rodriguez-Casero V, et al. Sodium channel a1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 2003; 61: 765-9. (Pubitemid 37174470)
79. Waxman SG, Black JA. Freeze-fracture ultrastructure of the perinodal astrocyte and associated glial junctions. Brain Res 1984; 308: 77-87. (Pubitemid 14067723)
80. Williams RW, Rakic P. Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol 1988; 278: 344-52. (Pubitemid 19004342)
81. Wolff M, Casse-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47 (Suppl 2): 45-8. (Pubitemid 44684620)
82. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006; 9: 1142-9. (Pubitemid 44306307)
83. Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH. Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 2011; 76: 594-600.
84. Zucca C, Redaelli F, Epifanio R, Zanotta N, Romeo A, Lodi M, et al. Cryptogenic epileptic syndromes related to SCN1A. Twelve novel mutations identified. Arch Neurol 2008; 65: 489-94. (Pubitemid 351549957)